Advanced search
Publication Cover
Leukemia & Lymphoma Volume 53, 2012 - Issue 3
Submit an article Journal homepage
386
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Low dose alemtuzumab in patients with fludarabine-refractory chronic lymphocytic leukemia

Giuseppe GrittiDepartment of Medical Sciences, University of Milan, Milan, Italy
,
Gianluigi RedaHematology-BMT Unit, Fondazione IRCCS Ca'Granda Ospedale Maggiore Policlinico, Milan, Italy
,
Francesco MauraHematology-BMT Unit, Fondazione IRCCS Ca'Granda Ospedale Maggiore Policlinico, Milan, Italy
,
Alfonso PiciocchiGIMEMA Data Center, Rome, Italy
,
Luca BaldiniDepartment of Medical Sciences, University of Milan, Milan, Italy;Hematology-BMT Unit, Fondazione IRCCS Ca'Granda Ospedale Maggiore Policlinico, Milan, Italy
,
Stefano MolicaOncology Unit, Pugliese-Ciaccio Hospital, Catanzaro, Italy
,
Antonino NeriDepartment of Medical Sciences, University of Milan, Milan, Italy;Hematology-BMT Unit, Fondazione IRCCS Ca'Granda Ospedale Maggiore Policlinico, Milan, Italy
&
Agostino CortelezziDepartment of Medical Sciences, University of Milan, Milan, Italy;Hematology-BMT Unit, Fondazione IRCCS Ca'Granda Ospedale Maggiore Policlinico, Milan, ItalyCorrespondence[email protected]
 show all
Pages 424-429 | Received 27 Jul 2011, Accepted 08 Sep 2011, Published online: 05 Jan 2012

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Sufia Butt Hassan, Jesper Freddie Sørensen, Barbara Nicola Olsen & Anders Elm Pedersen. (2014) Anti-CD40-mediated cancer immunotherapy: an update of recent and ongoing clinical trials. Immunopharmacology and Immunotoxicology 36:2, pages 96-104.
Read now
Loretta J Nastoupil, Rajni Sinha & Christopher R Flowers. (2013) The role of chemotherapy in managing chronic lymphocytic leukemia: optimizing combinations with targeted therapy. Expert Review of Anticancer Therapy 13:9, pages 1089-1108.
Read now

Articles from other publishers (6)

Mariarita Sciumè, Daniele Vincenti, Gianluigi Reda, Nicola Orofino, Ramona Cassin, Diana Giannarelli, Gianluca Gaidano, Davide Rossi & Agostino Cortelezzi. (2015) Low‐dose alemtuzumab in refractory/relapsed chronic lymphocytic leukemia: Genetic profile and long‐term outcome from a single center experience. American Journal of Hematology 90:11, pages 970-974.
Crossref
Tejas Suresh, Lisa X Lee, Jitesh Joshi & Stefan K Barta. (2014) New antibody approaches to lymphoma therapy. Journal of Hematology & Oncology 7:1.
Crossref
M. Fiegl, R. Stauder, M. Steurer, M. Mian, G. Hopfinger, Y. Brychtova, C. Skrabs, A. Zabernigg, F. Schmid, F. Haslbaur, G. Winder, A. Walder, A. Lang, D. Voskova, R. Greil, J. Mayer & G. Gastl. (2013) Alemtuzumab in chronic lymphocytic leukemia: final results of a large observational multicenter study in mostly pretreated patients. Annals of Hematology 93:2, pages 267-277.
Crossref
Piotr Smolewski, Magdalena Witkowska & Anna Korycka-Wołowiec. (2013) New Insights into Biology, Prognostic Factors, and Current Therapeutic Strategies in Chronic Lymphocytic Leukemia. ISRN Oncology 2013, pages 1-7.
Crossref
Kang Lu & Xin Wang. (2012) Therapeutic advancement of chronic lymphocytic leukemia. Journal of Hematology & Oncology 5:1.
Crossref
Jeremy L. Warner & Jon E. Arnason. (2012) Alemtuzumab use in relapsed and refractory chronic lymphocytic leukemia: a history and discussion of future rational use. Therapeutic Advances in Hematology 3:6, pages 375-389.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.